Stents Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The stents market encompasses vascular devices used in coronary and peripheral arteries, as well as non-vascular stents for urological, gastrointestinal, and respiratory applications. Growth has been sustained by increasing incidence of coronary artery disease, peripheral artery disease, and structural heart conditions worldwide. Product categories include bare-metal stents, drug-eluting stents, and bioabsorbable scaffolds, with hospitals, ambulatory surgery centers, and specialty clinics serving as primary end-users.

• •Market valued at approximately $14 billion in 2025 with projected long-term CAGR near 5.54%
• •Primary product segments include coronary stents, peripheral stents, and non-vascular stent variants
• •Key end-user channels are hospitals, ambulatory care centers, and specialty clinics

Rising global prevalence of cardiovascular diseases, driven by sedentary lifestyles, diabetes, obesity, and tobacco use, is the central growth catalyst. Aging demographics in developed nations and expanding healthcare infrastructure in emerging markets are enlarging the pool of patients eligible for stent-based revascularization. Concurrently, improvements in stent design, including thinner struts, biocompatible coatings, and better deliverability, are enhancing procedural success rates and physician adoption.

• •Escalating burden of coronary artery disease and peripheral artery disease across all regions
• •Growing preference for minimally invasive interventions over surgical alternatives
• •Continuous innovation in drug-eluting and bioabsorbable stent technologies improving patient outcomes

The market divides into vascular stents, dominated by coronary and peripheral indications, and non-vascular stents serving urological, esophageal, and pancreatic needs. North America and Europe hold the largest revenue shares due to advanced healthcare systems and high procedure volumes, while Asia-Pacific represents the fastest-growing region propelled by large patient populations, rising disease burden, and medical tourism. Material-wise, metallic stents crafted from cobalt-chromium and stainless steel dominate vascular applications, though polymeric and bioabsorbable options are gaining clinical ground.

• •Vascular stents constitute the largest product category, led by coronary and peripheral subsegments
• •Asia-Pacific anticipated as the highest-growth regional market through 2035
• •Metallic stents retain majority share, with bioabsorbable scaffolds capturing emerging clinical interest

What are the recent trends and outlook?

The industry is witnessing a gradual transition toward bioabsorbable stents and fully resorbable scaffolds intended to eliminate permanent implant-related complications. Value-based reimbursement models and healthcare cost-containment initiatives are influencing procurement patterns, particularly in price-sensitive markets. Through 2035, the global stents market is projected to reach approximately $26.68 billion, supported by expanding indications in structural heart disease, peripheral vascular interventions, and pediatric applications.

• •Bioabsorbable and bioresorbable scaffold technologies gaining regulatory and clinical acceptance
• •Integration of advanced imaging guidance and robotic-assisted delivery improving procedural precision
• •Long-term CAGR of roughly 5.54% expected to propel market toward $26.7 billion by 2035